tradingkey.logo
tradingkey.logo
Search

Acumen Pharmaceuticals Inc

ABOS
Add to Watchlist
2.920USD
+0.060+2.10%
Close 09-11 16:00ET
211.88MMarket Cap
LossP/E TTM

ABOS Financials

See Acumen Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
211.88M
Dividend TTM
0.00
P/E TTM
-1.58
EPS TTM
-1.86
Revenue
--
Net Profit
-102.33M
ROE
-93.23%
ROA
-67.01%

Acumen Pharmaceuticals Inc Earnings Date

Latest Release
Aug 12, 2026
EPS / Forecast
-0.45/-0.37
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
33.02%-0.45
31.05%-0.33
32.89%-0.41
11.86%-0.44
-97.77%-0.68
-91.33%-0.48
-117.46%-0.62
-107.35%-0.50
-20.79%-0.34
9.78%-0.25
9.53%-0.28
---0.24
---0.28
---0.28
---0.31
---0.74
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
Net Profit
20.10%-32.72M
27.99%-20.74M
32.34%-25.14M
11.13%-26.45M
-99.40%-40.95M
-93.61%-28.80M
-125.22%-37.15M
-129.72%-29.77M
-76.89%-20.54M
-31.54%-14.87M
-28.22%-16.50M
-20.98%-12.96M
-14.37%-11.61M
-23.86%-11.31M
-54.10%-12.87M
-174.47%-10.71M
83.46%-10.15M
66.19%-9.13M
-1005.83%-8.35M
-56.71%-3.90M
Debt to assets ratio
56.54%27.21%
60.89%23.23%
106.09%25.37%
93.90%21.55%
70.95%17.38%
43.87%14.44%
24.54%12.31%
--11.11%
--10.17%
--10.04%
--9.88%
----
----
----
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
Operating profit
22.02%-32.56M
30.36%-21.15M
36.36%-25.20M
17.83%-26.51M
-71.24%-41.75M
-70.87%-30.37M
-114.20%-39.60M
-101.17%-32.27M
-80.89%-24.38M
-35.32%-17.77M
-29.74%-18.49M
-41.05%-16.04M
-29.46%-13.48M
-42.68%-13.13M
-69.32%-14.25M
-188.97%-11.37M
-202.56%-10.41M
-142.71%-9.21M
-527.52%-8.41M
-58.03%-3.94M
Net Profit
20.10%-32.72M
27.99%-20.74M
32.34%-25.14M
11.13%-26.45M
-99.40%-40.95M
-93.61%-28.80M
-125.22%-37.15M
-129.72%-29.77M
-76.89%-20.54M
-31.54%-14.87M
-28.22%-16.50M
-20.98%-12.96M
-14.37%-11.61M
-23.86%-11.31M
-54.10%-12.87M
-174.47%-10.71M
83.46%-10.15M
66.19%-9.13M
-1005.83%-8.35M
-56.71%-3.90M
Current assets
-22.16%115.51M
-14.10%133.09M
-31.44%122.25M
-36.35%132.15M
-44.40%148.40M
-39.43%154.95M
-27.70%178.31M
-5.02%207.63M
78.49%266.92M
77.62%255.83M
36.76%246.62M
7.92%218.60M
-21.73%149.54M
-25.02%144.03M
-9.23%180.33M
-1.15%202.56M
170.72%191.05M
356.26%192.10M
--198.66M
--204.91M
Total current liabilities
88.44%46.85M
51.33%29.23M
8.69%30.01M
10.25%21.96M
61.78%24.86M
127.99%19.32M
112.84%27.61M
226.57%19.91M
80.13%15.37M
-3.50%8.47M
66.04%12.97M
-7.79%6.10M
66.17%8.53M
123.04%8.78M
51.78%7.81M
344.12%6.61M
13.63%5.13M
-87.38%3.94M
--5.15M
--1.49M
Total assets
-32.51%116.01M
-34.65%133.63M
-48.60%122.83M
-46.73%142.22M
-40.50%171.90M
-32.06%204.48M
-22.94%238.99M
-6.77%266.98M
62.86%288.91M
60.20%300.97M
57.75%310.13M
40.89%286.37M
-16.19%177.41M
-14.64%187.86M
-14.65%196.59M
-13.45%203.26M
190.20%211.68M
419.40%220.09M
--230.33M
--234.85M
Total liabilities
7.16%58.74M
-5.73%46.15M
-8.35%52.40M
-1.46%49.05M
21.91%54.82M
25.75%48.96M
32.50%57.18M
716.22%49.77M
427.09%44.97M
343.48%38.93M
452.38%43.15M
-7.79%6.10M
65.36%8.53M
119.58%8.78M
51.78%7.81M
344.12%6.61M
14.19%5.16M
-87.18%4.00M
--5.15M
--1.49M
Total equity
-51.09%57.26M
-43.75%87.48M
-61.26%70.43M
-57.10%93.17M
-52.01%117.08M
-40.65%155.52M
-31.90%181.82M
-22.50%217.20M
44.46%243.95M
46.32%262.03M
41.42%266.97M
42.52%280.27M
-18.23%168.87M
-17.12%179.09M
-16.17%188.78M
-15.73%196.65M
201.82%206.52M
1830.92%216.09M
--225.18M
--233.36M
Net operating income
43.22%-18.07M
29.29%-24.13M
29.83%-19.10M
-23.96%-30.49M
-92.40%-31.83M
-91.06%-34.12M
-227.34%-27.21M
-90.59%-24.60M
-41.77%-16.55M
-75.52%-17.86M
25.79%-8.31M
-40.53%-12.90M
-80.43%-11.67M
-22.61%-10.18M
-207.86%-11.20M
-19.45%-9.18M
-51.69%-6.47M
-250.17%-8.30M
-27.37%-3.64M
-499.22%-7.69M
Net investment
-32.44%26.00M
-148.13%-13.81M
-11.51%26.25M
499.83%40.51M
2.08%38.48M
411.74%28.69M
160.78%29.66M
88.99%-10.13M
240.74%37.70M
78.05%-9.20M
-139.02%-48.81M
-264.53%-92.00M
25.94%11.06M
-722.26%-41.93M
-103.98%-20.42M
159.42%55.92M
146516.67%8.79M
---5.10M
---10.01M
---94.10M
Net financing
---278.00K
99383.33%35.74M
122.22%2.00K
100.00%0.00
100.00%0.00
-100.51%-36.00K
-100.03%-9.00K
-100.03%-42.00K
11.72%-128.00K
--7.11M
596.32%29.13M
46778.33%122.76M
-935.71%-145.00K
----
41740.00%4.18M
-100.16%-263.00K
-100.04%-14.00K
----
-99.98%10.00K
--168.78M

FAQs

What are the current assets of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its current assets were 122.25M, with a year-on-year change of -31.44.

What are the total assets of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its total assets of Acumen Pharmaceuticals Inc were 122.83M, with a year-on-year change of -48.60.

What are the total liabilities of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Acumen Pharmaceuticals Inc were 52.40M, with a year-on-year change of -8.35.

What is the total equity of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its total equity of Acumen Pharmaceuticals Inc was 70.43M, with a year-on-year change of -61.26.

What is the net operating income of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Acumen Pharmaceuticals Inc was -123.83M, with a year-on-year change of -8.61.

What is the net investment of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its net investment of Acumen Pharmaceuticals Inc was 133.93M, with a year-on-year change of 178.87.

What is the net financing of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its net financing of Acumen Pharmaceuticals Inc was -34.00K, with a year-on-year change of -100.49.

What is the Earnings Per Share (EPS) of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.00, with a year-on-year change of -17.50.

What is the net income of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its net income was -121.33M, with a year-on-year change of -18.57.

What is the debt-to-asset ratio of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 25.37, with a year-on-year change of 106.09.

What is the Return on Equity (ROE) of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -96.20, with a year-on-year change of -110.96.

What is the Return on Assets (ROA) of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -67.07, with a year-on-year change of -79.95.

What is the operating profit of Acumen Pharmaceuticals Inc?

According to Acumen Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -123.83M, with a year-on-year change of -8.61.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.